Access cutting-edge shingles treatment through this clinical trial at a research site in Las Vegas. Study-provided care at no cost to qualified participants.
Access shingles specialists in Las Vegas at no cost
This study follows strict safety protocols and ethical guidelines
All study-related shingles treatment provided free
The purpose of this study is to assess the safety and immunogenicity of amezosvatein (CRV-101), an investigational vaccine compared to Shingrix® for the prevention of herpes zoster in adults aged 50 years and older
Sponsor: Curevo Inc
Check if you qualify for this shingles clinical trial in Las Vegas, NV
If you're searching for shingles treatment options in Las Vegas, NV, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Las Vegas research site is actively enrolling participants for this clinical trial. You'll receive care from experienced shingles specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.